Concert Pharmaceuticals, Inc. (CNCE): Price and Financial Metrics

Concert Pharmaceuticals, Inc. (CNCE)

Today's Latest Price: $7.83 USD

0.03 (0.38%)

Updated Apr 3 12:00am

Add CNCE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 337 in Biotech

See all "A" rated Strong Buy stocks

CNCE Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CNCE is 0.01 -- better than only 8.4% of US stocks.
  • With a price/sales ratio of 244.64, Concert Pharmaceuticals Inc has a higher such ratio than 98.93% of stocks in our set.
  • Revenue growth over the past 12 months for Concert Pharmaceuticals Inc comes in at -89.75%, a number that bests merely 0.88% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Concert Pharmaceuticals Inc, a group of peers worth examining would be QURE, CRNX, SNDX, INO, and FATE.
  • Visit CNCE's SEC page to see the company's official filings. To visit the company's web site, go to
CNCE Daily Price Range
CNCE 52-Week Price Range

CNCE Stock Price Chart More Charts

CNCE Price/Volume Stats

Current price $7.83 52-week high $13.95
Prev. close $7.80 52-week low $5.36
Day low $7.51 Volume 90,000
Day high $8.30 Avg. volume 200,489
50-day MA $9.63 Dividend yield N/A
200-day MA $9.24 Market Cap 232.06M

Concert Pharmaceuticals, Inc. (CNCE) Company Bio

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform (deuterated chemical entity platform) to create novel small molecule drugs. The company was founded in 2006 and is based in Lexington, Massachusetts.

CNCE Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CNCE Latest Social Stream

Loading social stream, please wait...

View Full CNCE Social Stream

CNCE Price Returns

1-mo -16.70%
3-mo -15.44%
6-mo 31.16%
1-year -40.00%
3-year -51.37%
5-year -49.16%
YTD -15.12%
2019 -26.49%
2018 -51.49%
2017 151.41%
2016 -45.76%
2015 42.42%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.697 seconds.